Reuters logo
BRIEF-Immunomedics says to seek expedited trial regarding venBio's actions
March 3, 2017 / 5:52 PM / 7 months ago

BRIEF-Immunomedics says to seek expedited trial regarding venBio's actions

March 3 (Reuters) - Immunomedics Inc:

* Continue to pursue legally justified relief against venBio Select Advisor LLC and venBio’s four director candidates in court

* Immunomedics intends to proceed with its annual meeting scheduled for Friday

* Intends to seek expedited discovery, expedited trial with respect to “questionable actions” actions employed by venBio

* Says will promptly seek appropriate relief in a proceeding in Delaware chancery court Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below